Effects of Zhuang medicine Shuanglu Tongnao Formula on neuroinflammation in ischemic stroke model rats via the P2X7R/NLRP3 pathway.
- Author:
Liangji GUO
1
;
Ligui GAN
1
;
Zujie QIN
2
;
Hongli TENG
2
;
Chenglong WANG
3
;
Jiangcun WEI
4
;
Xiaoping MEI
5
,
6
Author Information
1. Faculty of Zhuang Clinical Medicine, Guangxi University of Chinese Medicine, Nanning 530000, China.
2. Department of Classical Zhuang Medicine, International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 530201, China.
3. Ethnic Medical Management Office, International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 530201, China.
4. Zhuang-Yao Medicine Preparation Center, International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 530201, China.
5. Department of Encephalopathy, International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 530201, China. *Corresponding author, E-mail: zxim58@
6. com.
- Publication Type:Journal Article
- MeSH:
Animals;
NLR Family, Pyrin Domain-Containing 3 Protein/metabolism*;
Receptors, Purinergic P2X7/metabolism*;
Male;
Drugs, Chinese Herbal/pharmacology*;
Rats;
Ischemic Stroke/pathology*;
Rats, Sprague-Dawley;
Disease Models, Animal;
Signal Transduction/drug effects*;
Neuroinflammatory Diseases/metabolism*;
Tumor Necrosis Factor-alpha/metabolism*;
Nitric Oxide Synthase Type II/metabolism*;
Interleukin-10/metabolism*;
Brain Ischemia/drug therapy*;
Microglia/metabolism*
- From:
Chinese Journal of Cellular and Molecular Immunology
2025;41(11):985-991
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effects of Shuanglu Tongnao Formula on neuroinflammation in ischemic stroke (IS) rats via the P2X purinoceptor 7 receptor (P2X7R)/NLR family pyrin domain-containing 3 (NLRP3) pathway. Methods The rats were divided into five groups: the IS group, control group, Shuanglu Tongnao Formula group, P2X7R inhibitor brilliant blue G (BBG) group, and Shuanglu Tongnao Formula combined with P2X7R activator adenosine triphosphate (ATP) group, with 18 rats in each group. Except for the control group, rats in all other groups were used to construct an IS model using the suture method. After successful modeling, the drug was given once a day for 2 weeks. Neurological function scores and cerebral infarction volume ratios were measured in rats. Pathological examination of the ischemic penumbra brain tissue was performed. Immunofluorescence staining was used to quantify the proportions of microglia co-expressing both inducible nitric oxide synthase (iNOS) and ionized calcium-binding adapter molecule 1 (Iba1), as well as arginase 1 (Arg1) and Iba1, in the ischemic penumbra brain tissue. ELISA was used to detect tumor necrosis factor-alpha (TNF-α), transforming growth factor-beta (TGF-β), interleukin 6 (IL-6) and IL-10 in the ischemic penumbra brain tissue. Western blotting was used to measure P2X7R, NLRP3, and IL-1β proteins in the ischemic penumbra brain tissue. Results Compared with the control group, the IS group showed disordered neuronal arrangement, nuclear condensation, and obvious infiltration of inflammatory cells in the ischemic penumbra; significantly elevated neurological function scores, cerebral infarction volume ratios, proportions of microglia co-expressing iNOS and Iba1, and levels of TNF-α, IL-6, and P2X7R, NLRP3, IL-1β proteins; along with reduced proportions of microglia co-expressing Arg1 and Iba1 and levels of TGF-β and IL-10. Compared with the IS group, the Zhuang medicine Shuanglu Tongnao Formula and BBG groups demonstrated alleviated brain tissue damage; reduced neurological function scores, cerebral infarction volume ratios, proportions of microglia co-expressing iNOS and Iba1, and levels of TNF-α, IL-6, and P2X7R, NLRP3, IL-1β proteins; along with increased proportions of microglia co-expressing Arg1 and Iba1 and levels of TGF-β and IL-10. ATP reversed the effects of Zhuang medicine Shuanglu Tongnao Formula on microglial polarization and neuroinflammation in IS rats. Conclusion Zhuang medicine Shuanglu Tongnao Formula may promote the transformation of microglia from M1 type to M2 type by inhibiting the P2X7R/NLRP3 pathway, thereby improving neuroinflammation in IS rats.
